Advanced search
Publication Cover
Patient Preference and Adherence Volume 9, 2015 - Issue
Submit an article Journal homepage
67
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Patient-reported outcomes and considerations in the management of COPD: focus on aclidinium

Jose Luis Lopez-Campos1 Unidad Médico-Quirúrgica de Enfermedades Respiratorias, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/Universidad de Sevilla, Sevilla, Spain;2 CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, SpainCorrespondence[email protected]
,
Carmen Calero1 Unidad Médico-Quirúrgica de Enfermedades Respiratorias, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/Universidad de Sevilla, Sevilla, Spain;2 CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain
,
Cecilia Lopez-Ramirez1 Unidad Médico-Quirúrgica de Enfermedades Respiratorias, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/Universidad de Sevilla, Sevilla, Spain
,
Maria Isabel Asensio-Cruz1 Unidad Médico-Quirúrgica de Enfermedades Respiratorias, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/Universidad de Sevilla, Sevilla, Spain
,
Eduardo Márquez-Martín1 Unidad Médico-Quirúrgica de Enfermedades Respiratorias, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/Universidad de Sevilla, Sevilla, Spain
&
Francisco Ortega-Ruiz1 Unidad Médico-Quirúrgica de Enfermedades Respiratorias, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/Universidad de Sevilla, Sevilla, Spain;2 CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain
Pages 95-104 | Published online: 17 Jan 2015

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Mario Cazzola, Paola Rogliani, Josuel Ora & Maria Gabriella Matera. (2016) Treatment options for moderate-to-very severe chronic obstructive pulmonary disease. Expert Opinion on Pharmacotherapy 17:7, pages 977-988.
Read now
Pinar Yildiz, Mesut Bayraktaroglu, Didem Gorgun & Funda Secik. (2016) Bronchodilator efficacy of 18 μg once-daily tiotropium inhalation via Discair® versus HandiHaler® in adults with chronic obstructive pulmonary disease: randomized, active-controlled, parallel-group, open-label, Phase IV trial. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 2859-2867.
Read now

Articles from other publishers (4)

Pinar Yildiz, Mesut Bayraktaroglu, Didem Gorgun & Kivanc Yuksel. (2019) Bronchodilator Efficacy of a Single-Dose 12/400-µg Formoterol/Budesonide Combination as a Dry Powder for Inhalation Delivered by Discair® in Adult Patients with Moderate-to-Severe Stable COPD: Open-Label, Single-Arm, Phase IV Trial. Clinical Drug Investigation 39:10, pages 991-1001.
Crossref
S N Avdeev & N V Trushenko. (2019) New opportunities of dual bronchodilation therapy for patients with chronic obstructive pulmonary disease. Terapevticheskii arkhiv 91:3, pages 76-85.
Crossref
Qiuying Chen, Ruba S. Deeb, Yuliang Ma, Michelle R. Staudt, Ronald G. Crystal & Steven S. Gross. (2015) Serum Metabolite Biomarkers Discriminate Healthy Smokers from COPD Smokers. PLOS ONE 10:12, pages e0143937.
Crossref
Björn Laudahn & Sören Schmidtmann. (2015) Wie praxisrelevant sind die GOLD-Empfehlungen für den ambulanten Alltag bei COPD?. Pneumo News 7:5, pages 53-59.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.